TY - JOUR
TI - A Randomized Phase 2 Trial of Bortezomib--Dexamethasone Versus Bortezomib--Dexamethasone with Added Cyclophosphamide or Lenalidomide in Multiple Myeloma Patients Achieving Stable Disease After Four Cycles of Bortezomib--Dexamethasone Administered as Second-Line Treatment.
AU - Dimopoulos, Meletios A
AU - Roddie, Huw
AU - Beksac, Meral
AU - Benboubker, Lotfi
AU - Jurgutis, Romualdas
AU - Langer, Christian
AU - de la Rubia, Javier
AU - Casado, Luis Felipe
AU - Kuliczkowski, Kazimierz
AU - Macukanovic-Golubovic, Lena
AU - others
JO - Blood cancer journal
PY - 2009
VL - 114
TODO - 22
SP - 4937
PB - Content Repository Only!
SN - null
TODO - null
TODO - null
TODO - null
ER -